Association of statin pre-treatment with baseline stroke severity and outcome in patients with acute ischemic stroke and received reperfusion treatment: An observational study

Abstract

Background:

Statins have an important role in stroke prevention, especially in high-risk populations and may also affect the initial stroke severity and outcomes in patients taking them before an ischemic stroke.

Aims:

Our aim was to evaluate the association of statin pre-treatment with the severity in acute ischemic stroke (AIS).

Methods:

We analyzed AIS patients received intravenous thrombolysis (IVT) and/or endovascular thrombectomy (EVT) and recorded in the SITS International Thrombolysis and Thrombectomy Registry from 2011 to 2017. We identified patients with statin information at baseline. The primary outcome was baseline National Institutes of Health Stroke Scale (NIHSS) score. Secondary outcomes were NIHSS score at 24 h, symptomatic intracerebral hemorrhage (SICH) and functional outcome at 90 days after acute intervention. Multivariable linear and logistic regression and propensity score matching (PSM) was used to quantify the effect of statin pre-treatment.

Results:

Of 93,849 patients, 23,651 (25.2%) were treated with statins prior the AIS. Statin pre-treatment group was older and had higher comorbidity. Median NIHSS at baseline was similar between groups. In the adjusted and PSM analysis, statin pre-treatment was inversely associated with baseline NIHSS (odds ratio (OR) = 0.77, 95% confidence interval (CI) = 0.6–0.99 and OR for PSM 0.73, 95% CI = 0.54–0.99, p = 0.004) and independently associated with mild stroke defined as NIHSS ⩽8 in adjusted and PSM analysis (OR = 1.21, 95% CI = 1.1–1.34, p < 0.001 and OR for PSM 1.17, 95% CI = 1.05–1.31, p = 0.007). Regarding secondary outcomes, there were no differences in functional outcomes, death nor SICH rates between groups.

Conclusion:

Prior treatment with statins was associated with lower NIHSS at baseline. However, this association did not translate into any difference regarding functional outcome at 90 days. No association was found regarding SICH. These findings indicate the need of further studies to assess the effect on statin pre-treatment on initial stroke severity.

Keywords

Stroke statins prevention neuroprotection severity lipids

Get full access to this article

View all access options for this article.

References

Kernan

Ovbiagele

Black

, et al Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45: 2160–2236.

Meschia

Bushnell

Boden-Albala

, et al Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45: 3754–3832.

Oesterle

Laufs

Liao

. Pleiotropic effects of statins on the cardiovascular system. Circ Res 2017; 120: 229–243.

van der Most

Dolga

Nijholt

, et al Statins: mechanisms of neuroprotection. Prog Neurobiol 2009; 88: 64–75.

Tsivgoulis

Kadlecová

Kobayashi

, et al Safety of statin pretreatment in intravenous thrombolysis for acute ischemic stroke. Stroke 2015; 46: 2681–2684.

Tsivgoulis

Katsanos

Sharma

, et al Statin pretreatment is associated with better outcomes in large artery atherosclerotic stroke. Neurology 2016; 86: 1103–1111.

Min

Shao

, et al Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke. Neural Regen Res 2013; 8: 2144–2154.

Cappellari

Bovi

Moretto

, et al The THRombolysis and statins (THRaST) study. Neurology 2013; 80: 655–661.

Minhas

Wang

Armia

, et al Lipid-lowering pretreatment and outcome following intravenous thrombolysis for acute ischaemic stroke: a post hoc analysis of the enhanced control of hypertension and thrombolysis stroke study trial. Cerebrovasc Dis 2018; 45: 213–220.

10.

Wahlgren

Ahmed

Dávalos

, et al Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST): an observational study. Lancet 2007; 369: 275–282.

11.

National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group. Recombinant tissue plasminogen activator for minor strokes: the National institute of neurological disorders and stroke rt-PA stroke study experience. Ann Emerg Med 2005; 46: 243–252.

12.

Hacke

Kaste

Fieschi

, et al Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998; 352: 1245–1251.

13.

The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581–1587.

14.

Endres

. Statins and stroke. J Cereb Blood Flow Metab 2005; 25: 1093–1110.

15.

García-Bonilla

Campos

Giralt

, et al Evidence for the efficacy of statins in animal stroke models: a meta-analysis. J Neurochem 2012; 122: 233–243.

16.

Ní Chróinín

Asplund

Åsberg

, et al Statin therapy and outcome after ischemic stroke: Systematic review and meta-analysis of observational studies and randomized trials. Stroke 2013; 44: 448–456.

17.

Hong

Lee

. Statins in acute ischemic stroke: a systematic review. J Stroke 2015; 17: 282–301.

18.

Amarenco

Bogousslavsky

Callahan

, et al High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549–559.

19.

Goldstein

Amarenco

Szarek

, et al Hemorrhagic stroke in the stroke prevention by aggressive reduction in cholesterol levels study. Neurology 2008; 70: 2364–2370.

20.

Martinez-Ramirez

Delgado-Mederos

Marin

, et al Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: results from a case-control study and a meta-analysis. J Neurol 2012; 259: 111–118.

21.

Scheitz

Seiffge

Tütüncü

, et al Dose-related effects of statins on symptomatic intracerebral hemorrhage and outcome after thrombolysis for ischemic stroke. Stroke 2014; 45: 509–514.

22.

Engelter

Soinne

Ringleb

, et al IV thrombolysis and statins. Neurology 2011; 77: 888–895.

23.

Montaner

Bustamante

García-Matas

, et al Combination of thrombolysis and statins in acute stroke is safe. Results of the STARS randomized trial (stroke treatment with acute reperfusion and simvastatin). Stroke 2016; 47: 2870–2873.

24.

Logallo

Kvistad

Naess

, et al Mild stroke: Safety and outcome in patients receiving thrombolysis. Acta Neurol Scand Suppl 2014; 198: 37–40.

25.

Willey

Khatri

Khoury

, et al Variability in the use of intravenous thrombolysis for mild stroke: experience across the SPOTRIAS network. J Stroke Cerebrovasc Dis 2013; 22: 318–322.

26.

Martínez-Sánchez

Fuentes

Martínez-Martínez

, et al

Treatment with statins and ischemic stroke severity: does the dose matter?

Neurology 2013; 80: 1800–1805.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.19 MB